Community Health Plans Are Serious: Support Major Federal Action to Reduce Prescription Drug Costs
ACHP backs concrete efforts by the federal government to reign in high drug costs, such as empowering Medicare negotiations.
ACHP backs concrete efforts by the federal government to reign in high drug costs, such as empowering Medicare negotiations.
This issue brief outlines how a shift to value-based care can improve health outcomes, lower costs and improve patient satisfaction.
Legislation can help check drug makers ability to hike prices and inject more competition into the market — helping lower prices for all.
We may be winning battles against cancer. But we will lose the war if we don’t do something about the rising cost of drugs in the United States.
Biosimilars can help provide financial relief for millions struggling to pay astronomical drug prices.
ACHP is the voice of a unique approach in health care today, one that puts the patient at the center with plans and clinical teams collaborating to improve health outcomes and reduce costs. Our advocacy focuses on providing policymakers with tested solutions, rooted in a model that is proven to deliver better value for patients, employers and taxpayers.